Survival analysis and AML development in patients with de novo myelodysplastic syndromes: Comparison of six different prognostic scoring systems

Annals of Hematology

Volumn 80, Issue 5, 2001, Pages 272-277

  Sperr, W R ^a   Wimazal, F ^a   Kundi, M ^a   Fonatsch, C ^a   Thalhammer Scherrer, R ^a   Schernthaner, G H ^a   Schwarzinger, I ^a   Haas, O A ^a   Geissler, K ^a   Lechner, K ^a   Valent, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

AML transformation; MDS; Scoring system; Survival

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE COUNT;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034986843     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000280     Document Type: Article

References (24)

1. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
2. Risk assessment in primary myelodysplastic syndromes: Validation of the Düsseldorf score
3. International prognostic scoring system and other prognostic scoring systems for myelodysplastic syndrome
4. Proposals for the classification of the myelodysplastic syndromes
5. The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia
6. Treatment and prognostic factors in myelodysplastic syndromes
7. Molecular pathogenesis of the myelodysplastic syndromes
8. Epidemiologic perspectives on myelodysplastic syndromes and leukemia
9. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute leukemias and myelodysplastic syndromes
10. Regression models and life tables
11. Application of the International Scoring System for myelodysplasia to M.D. Anderson patients
12. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)
13. The smouldering myeloid leukemic states: Clinical and biologic features
14. Risk factors and their relationship to the prognosis of myelodysplastic syndromes
15. International scoring system for evaluating prognosis in myelodysplastic syndromes
16. An international system for human cytogenetic nomenclature
17. Nonparametric estimation from incomplete observations
18. Advances in the therapy of myelodysplastic syndromes
19. Comparison of prognostic scoring systems for myelodysplastic syndromes: A Korean multicenter study
20. Cytogenetic analysis has strong prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system. A report on 408 cases
21. Myelodysplastic syndromes: A scoring system with prognostic significance
22. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes. A multi-variate analysis of prognostic factors in 370 patients
23. Prognostic factors and scoring systems in myelodysplastic syndromes
24. Clinical implications of chromosomal abnormalities in 401 patients with MDS: A multicentric study in Japan